Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia.

MLA

Sun, GuiLan, et al. “Mono-PEGylated Radix Ophiopogonis Polysaccharide for the Treatment of Myocardial Ischemia.” European Journal of Pharmaceutical Sciences, vol. 49, no. 4, July 2013, pp. 629–36. EBSCOhost, https://doi.org/10.1016/j.ejps.2013.05.020.

APA

Sun, G., Lin, X., Shen, L., Wu, F., Xu, D., Ruan, K., & Feng, Y. (2013). Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. European Journal of Pharmaceutical Sciences, 49(4), 629–636. https://doi.org/10.1016/j.ejps.2013.05.020

Chicago

Sun, GuiLan, Xiao Lin, Lan Shen, Fei Wu, DeSheng Xu, KeFeng Ruan, and Yi Feng. 2013. “Mono-PEGylated Radix Ophiopogonis Polysaccharide for the Treatment of Myocardial Ischemia.” European Journal of Pharmaceutical Sciences 49 (4): 629–36. doi:10.1016/j.ejps.2013.05.020.